Company news
Autobio Diagnostics Co., Ltd. Class A (SSE:603658) news
Autobio Diagnostics Co., Ltd. Class A news releases on 6ix. Latest, Sep 22, 2026: "AUTOBIO DIAGNOSTICS CO., LTD."Announcement on Convening the 2026…
Press releases & updates
"AUTOBIO DIAGNOSTICS CO., LTD."Announcement on Convening the 2026 Semi-annual Performance Briefing
September 21, 2026
"AUTOBIO DIAGNOSTICS CO., LTD."Announcement on Completion of Industrial and Commercial Registration Changes by Wholly-owned Subsidiary
September 17, 2026
"AUTOBIO DIAGNOSTICS CO., LTD."Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
September 14, 2026
"AUTOBIO DIAGNOSTICS CO., LTD."Announcement on Redemption and Progress of Cash Management Using Idle Raised Funds
September 7, 2026
"Autobio Diagnostics Co., Ltd."Announcement on Company and Its Second-Tier Subsidiary Obtaining Medical Device Registration Certificate
August 28, 2026
"AUTOBIO DIAGNOSTICS CO., LTD."Announcement on Resolutions of the 13th Meeting of the 5th Board of Directors
August 24, 2026
"AUTOBIO DIAGNOSTICS CO., LTD."Announcement on Cancellation of Medical Device Business License and Filing Record for Class II Medical Device Business by Second-Tier Subsidiary
August 4, 2026
"AUTOBIO DIAGNOSTICS CO., LTD."Announcement on Company and Its Wholly-Owned Subsidiary Obtaining Medical Device Registration Certificate
July 8, 2026
Announcement on Redemption and Progress of Using Idle Raised Funds for Cash Management
June 12, 2026
Announcement on Convening Performance Briefing for 2025 and Q1 2026
May 22, 2026
Announcement on Implementation of Dividend Distribution for 2025
May 21, 2026
Announcement on Company and Its Wholly-Owned Subsidiary Obtaining Medical Device Registration Certificate
May 19, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
May 13, 2026
Announcement on Redemption of Using Idle Raised Funds for Cash Management
May 7, 2026
Special Report on Deposit, Management and Actual Use of Raised Funds in 2025
April 22, 2026
Announcement on Obtaining Medical Device Registration Certificate
March 30, 2026
Announcement on Conducting Foreign Exchange Hedging Business
January 20, 2026
Announcement on the Wholly-owned Subsidiary and Secondary Subsidiary Certified as High-tech Enterprises
January 16, 2026
Announcement on the Wholly-Owned Subsidiary and Secondary Subsidiary Re-certified as High-tech Enterprises
December 31, 2025
Announcement on Company and Its Tier-II Subsidiary Obtaining Medical Device Registration Certificate
December 30, 2025
Announcement on Using Idle Raised Funds for Cash Management
December 9, 2025
Announcement on Company and Its Subsidiary Obtaining Medical Device Registration Certificate
December 2, 2025
Announcement on Convening the Q3 2025 Performance Briefing
November 28, 2025
Announcement on Election of Employee Representative Directors for the 5th Board of Directors
November 14, 2025
Supplementary Announcement on Correction of Notice on the 2nd Extraordinary General Meeting in 2025
November 6, 2025
Announcement on Revision and Formulation of Corporate Internal Governance Systems
October 29, 2025
Announcement on Change of Sponsor Representative
October 24, 2025
Announcement on Change Registration of Medical Device Business License and the Drug Business License by Wholly-owned Subsidiary
October 13, 2025
Announcement on Convening the 2025 Semi-annual Performance Briefing
September 12, 2025
Announcement on Resolutions of the 6th Meeting of the 5th Board of Supervisors
August 21, 2025
Announcement on Opening New Special Account for Raised Funds and Signing Agreement on Supervision
July 31, 2025
Announcement on Completing the Performance of the "Settlement Agreement"
July 28, 2025
Announcement on Resolutions of the 6th Meeting of the 5th Board of Directors
July 25, 2025
Announcement on Progress in Using Idle Raised Funds for Cash Management
July 2, 2025
Announcement on Opening Special Settlement Account for Cash Management Products of Raised Funds
June 30, 2025
Announcement on Completing Industrial and Commercial Change Registration
June 20, 2025
Announcement on Result of Shareholding Reduction by Shareholder with Over 5% Shares
June 16, 2025
Announcement on Cancellation and Termination of Outward Investment by Holding Subsidiary
June 9, 2025
Announcement on Opening Special Settlement Account for Cash Management Products Using Raised Funds
June 5, 2025
Announcement on Implementation of Dividend Distribution for 2024
May 18, 2025
Announcement on Attending 2025 Online Collective Reception Day for Investors of Listed Companies in Henan Jurisdiction
May 14, 2025
Announcement on Convening the 2024 Annual and Q1 2025 Performance Briefing
May 9, 2025
Announcement on Resolution of the 2024 Annual General Meeting
May 8, 2025
Announcement on Change Registration of Medical Device Production License by Wholly-Owned Subsidiary
May 7, 2025
Announcement on Provision of Online Voting Reminder Service for General Meeting
April 30, 2025
Announcement on Completion of Industrial and Commercial Change Registration by Wholly-Owned Subsidiary
March 26, 2025
Supplementary Announcement on Implementation Results of Repurchasing Shares and Share Changes
February 28, 2025
Announcement on Shareholding Reduction Plan for Shareholders with Over 5% Shares
February 21, 2025
Announcement on Completion of Controlling Shareholder's Share Increase Plan
February 20, 2025
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025
February 17, 2025